Finally, PrEP choices! But will clients ever have a choice?
作者信息
Green Kimberly E, Ngure Kenneth, Eakle Robyn, Phanuphak Nittaya, Reed Jason
机构信息
PATH, Geneva, Switzerland.
Harvard University, Boston, Massachusetts, USA.
出版信息
J Int AIDS Soc. 2025 Jul;28 Suppl 2(Suppl 2):e26505. doi: 10.1002/jia2.26505.
Abstract
摘要
相似文献
1
Finally, PrEP choices! But will clients ever have a choice?最后，关于暴露前预防的选择！但客户真的会有选择吗？
J Int AIDS Soc. 2025 Jul;28 Suppl 2(Suppl 2):e26505. doi: 10.1002/jia2.26505.
2
Online delivery of oral HIV pre- and post-exposure prophylaxis: findings from the ePrEP Kenya pilot.口服艾滋病毒暴露前和暴露后预防药物的在线配送：肯尼亚电子预防试点项目的结果
J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26468. doi: 10.1002/jia2.26468.
3
"People have options": a qualitative study of experiences and influences of PrEP choice among women in South Africa.“人们有选择”：对南非女性中暴露前预防（PrEP）选择的经历及影响的定性研究
J Int AIDS Soc. 2025 Jul;28 Suppl 2(Suppl 2):e26462. doi: 10.1002/jia2.26462.
4
User and healthcare provider early experiences with the PrEP ring: a quantitative study on the introduction of a new PrEP method in Eswatini.使用者与医疗服务提供者使用暴露前预防环的早期体验：斯威士兰引入一种新的暴露前预防方法的定量研究
J Int AIDS Soc. 2025 Jul;28 Suppl 2(Suppl 2):e26490. doi: 10.1002/jia2.26490.
5
Seizing the moment: the potential of PrEP choice and innovation to transform HIV prevention.把握时机：暴露前预防选择与创新在变革艾滋病毒预防方面的潜力。
J Int AIDS Soc. 2025 Jul;28 Suppl 2(Suppl 2):e26498. doi: 10.1002/jia2.26498.
6
PrEP15-19 Choices: an implementation study protocol of HIV prevention with oral and long-acting injectable cabotegravir PrEP in real-word settings among sexual and gender minority adolescents in Brazil.PrEP15 - 19选择：一项在巴西性少数和性别少数青少年的现实环境中使用口服和长效注射卡博特韦进行HIV预防的实施研究方案。
BMJ Open. 2025 Jan 20;15(1):e083146. doi: 10.1136/bmjopen-2023-083146.
7
Brief Report: HIV Pre-exposure Prophylaxis Awareness and Use Among Rakai Community Cohort Study Youth Aged 15-24.简短报告：拉凯社区队列研究中15 - 24岁青年对艾滋病病毒暴露前预防的知晓情况与使用情况
J Acquir Immune Defic Syndr. 2025 May 1;99(1):41-46. doi: 10.1097/QAI.0000000000003640.
8
A modified pharmacy provider-led delivery model of oral HIV pre- and post-exposure prophylaxis in Kenya: a pilot study extension.肯尼亚一种经改良的由药房提供者主导的口服艾滋病毒暴露前和暴露后预防交付模式：一项试点研究扩展
J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26467. doi: 10.1002/jia2.26467.
9
Improving HIV Prevention Among Heterosexual Men Seeking Sexually Transmitted Infection Services in Malawi: Protocol for a Type I Effectiveness-Implementation Hybrid Randomized Controlled Trial of Systems Navigator-Delivered Integrated Prevention Package (HPTN 112-NJIRA Study).在马拉维寻求性传播感染服务的异性恋男性中加强艾滋病预防：系统导航员提供的综合预防套餐的 I 型有效性-实施混合随机对照试验方案（HPTN 112-NJIRA 研究）
JMIR Res Protoc. 2025 Jun 18;14:e72981. doi: 10.2196/72981.
10
Optimising HIV pre-exposure prophylaxis and testing strategies in men who have sex with men in Australia, Thailand, and China: a modelling study and cost-effectiveness analysis.在中国、澳大利亚和泰国优化男男性行为者的 HIV 暴露前预防和检测策略：一项建模研究和成本效益分析。
Lancet Glob Health. 2024 Feb;12(2):e243-e256. doi: 10.1016/S2214-109X(23)00536-3.
引用本文的文献
1
Expanding access to a choice-based multi-method PrEP market for HIV prevention.扩大获得基于选择的多种方法的预防艾滋病病毒暴露前预防（PrEP）市场的机会。
J Int AIDS Soc. 2025 Jul;28 Suppl 2(Suppl 2):e26512. doi: 10.1002/jia2.26512.
本文引用的文献
1
The cost of the plunge: the impact and cost of a cessation of PEPFAR-supported services in South Africa.急转直下的代价：南非停止接受总统紧急艾滋病救援计划（PEPFAR）支持的服务所产生的影响及代价。
AIDS. 2025 Aug 1;39(10):1476-1480. doi: 10.1097/QAD.0000000000004272. Epub 2025 Jun 20.
2
Cost-effectiveness of lenacapavir for PrEP in Africa.非洲地区用于暴露前预防的来那卡帕韦的成本效益
Lancet HIV. 2024 Nov;11(11):e722-e723. doi: 10.1016/S2352-3018(24)00242-X. Epub 2024 Sep 20.
3
Preferences for Long-Acting PrEP Products Among Women and Girls: A Quantitative Survey and Discrete Choice Experiment in Eswatini, Kenya, and South Africa.妇女和女童对长效避孕产品的偏好：在斯威士兰、肯尼亚和南非进行的定量调查和离散选择实验。
AIDS Behav. 2024 Mar;28(3):936-950. doi: 10.1007/s10461-023-04202-0. Epub 2023 Nov 16.
4
Cost-effectiveness of self-injected DMPA-SC compared with health-worker-injected DMPA-IM in Senegal.在塞内加尔，自我注射皮下埋植剂醋酸甲羟孕酮（DMPA-SC）与卫生工作者注射的肌肉注射用醋酸甲羟孕酮（DMPA-IM）的成本效益比较。
Contracept X. 2019;1:100012. doi: 10.1016/j.conx.2019.100012.
5
Determinants of heterosexual men's demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South Africa.城市南非异性恋男性对长效注射型 HIV 暴露前预防（PrEP）需求的决定因素。
BMC Public Health. 2019 Jul 24;19(1):996. doi: 10.1186/s12889-019-7276-1.
Zotero 插件